Audie Rice

3.2k total citations
28 papers, 1.7k citations indexed

About

Audie Rice is a scholar working on Molecular Biology, Hematology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Audie Rice has authored 28 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 13 papers in Hematology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Audie Rice's work include Multiple Myeloma Research and Treatments (11 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Glycosylation and Glycoproteins Research (4 papers). Audie Rice is often cited by papers focused on Multiple Myeloma Research and Treatments (11 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Glycosylation and Glycoproteins Research (4 papers). Audie Rice collaborates with scholars based in United States, Germany and France. Audie Rice's co-authors include Michael J. Banda, Gail L. Griffin, Robert M. Senior, Gerald McMahon, Congxin Liang, Gary C. Starling, Cho Tang, Li Sun, Randall Schreck and Kenneth E. Lipson and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Audie Rice

28 papers receiving 1.6k citations

Peers

Audie Rice
Masaki Ri Japan
Jiro Kikuchi Japan
J I Johnson United States
Lisa Roberts United States
Francisco Adrián United States
Joanna Opalinska United States
Maeva Dufies France
G Schwab United States
Amanda L. Christie United States
Gerrard Teoh United States
Masaki Ri Japan
Audie Rice
Citations per year, relative to Audie Rice Audie Rice (= 1×) peers Masaki Ri

Countries citing papers authored by Audie Rice

Since Specialization
Citations

This map shows the geographic impact of Audie Rice's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Audie Rice with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Audie Rice more than expected).

Fields of papers citing papers by Audie Rice

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Audie Rice. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Audie Rice. The network helps show where Audie Rice may publish in the future.

Co-authorship network of co-authors of Audie Rice

This figure shows the co-authorship network connecting the top 25 collaborators of Audie Rice. A scholar is included among the top collaborators of Audie Rice based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Audie Rice. Audie Rice is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Balasa, Balaji, Nicole A. Belmar, Melvin Fox, et al.. (2014). Elotuzumab enhances natural killer cell activation and myeloma cell killing through interleukin-2 and TNF-α pathways. Cancer Immunology Immunotherapy. 64(1). 61–73. 123 indexed citations
2.
Bakan, Courtney E., Craig C. Hofmeister, Yvonne A. Efebera, et al.. (2013). Elotuzumab directly enhances NK cell cytotoxicity against myeloma via CS1 ligation: evidence for augmented NK cell function complementing ADCC. Cancer Immunology Immunotherapy. 62(12). 1841–1849. 236 indexed citations
3.
Bakan, Courtney E., Hakju Kwon, Balaji Balasa, et al.. (2011). The effect of elotuzumab on natural killer (NK) cell function against multiple myeloma (MM).. Journal of Clinical Oncology. 29(15_suppl). 2572–2572. 3 indexed citations
4.
Rhee, Frits van, Susann Szmania, Myles Dillon, et al.. (2009). Combinatorial efficacy of anti-CS1 monoclonal antibody elotuzumab (HuLuc63) and bortezomib against multiple myeloma. Molecular Cancer Therapeutics. 8(9). 2616–2624. 142 indexed citations
5.
6.
O’Neill, Roger A., Erik Gentalen, J. Jared Gossett, et al.. (2005). Capillary electrophoresis immunoassay.. Cancer Research. 65. 92–92. 1 indexed citations
7.
Tsonis, Panagiotis A., et al.. (2004). Effects of a CDK inhibitor on lens regeneration. Wound Repair and Regeneration. 12(1). 24–29. 7 indexed citations
8.
Bandt, Michel De, Véronique Ollivier, M Grossin, et al.. (2003). Blockade of Vascular Endothelial Growth Factor Receptor I (VEGF-RI), but not VEGF-RII, Suppresses Joint Destruction in the K/BxN Model of Rheumatoid Arthritis. The Journal of Immunology. 171(9). 4853–4859. 103 indexed citations
9.
Moshinsky, Deborah, Cornelia Bellamacina, D.C. Boisvert, et al.. (2003). SU9516: biochemical analysis of cdk inhibition and crystal structure in complex with cdk2. Biochemical and Biophysical Research Communications. 310(3). 1026–1031. 44 indexed citations
10.
Wang, Xueyan, Phuong Le, Congxin Liang, et al.. (2003). Potent and selective inhibitors of the Met [hepatocyte growth factor/scatter factor (HGF/SF) receptor] tyrosine kinase block HGF/SF-induced tumor cell growth and invasion.. PubMed. 2(11). 1085–92. 93 indexed citations
11.
Ismail, Ismail Hassan, Deborah Moshinsky, Audie Rice, et al.. (2003). SU11752 inhibits the DNA-dependent protein kinase and DNA double-strand break repair resulting in ionizing radiation sensitization. Oncogene. 23(4). 873–882. 63 indexed citations
12.
Sun, Li, Deborah Moshinsky, Hui Chen, et al.. (2003). A Selective and Oral Small Molecule Inhibitor of Vascular Epithelial Growth Factor Receptor (VEGFR)-2 and VEGFR-1 Inhibits Neovascularization and Vascular Permeability. Journal of Pharmacology and Experimental Therapeutics. 306(3). 838–845. 32 indexed citations
13.
Lane, Mary Ellen, Bo Yu, Audie Rice, et al.. (2001). A novel cdk2-selective inhibitor, SU9516, induces apoptosis in colon carcinoma cells.. PubMed. 61(16). 6170–7. 124 indexed citations
14.
Alvi, Khisal A., et al.. (1999). Asterriquinones Produced by Aspergillus candidus Inhibit Binding of the Grb-2 Adapter to Phosphorylated EGF Receptor Tyrosine Kinase.. The Journal of Antibiotics. 52(3). 215–223. 24 indexed citations
15.
Powell, Thomas, Randall Schreck, Audie Rice, et al.. (1995). A Tumor-Derived Protein which Provides T-Cell Costimulation through Accessory Cell Activation. Journal of Immunotherapy. 17(4). 209–221. 49 indexed citations
16.
Rice, Audie & Michael J. Banda. (1995). Neutrophil Elastase Processing of Gelatinase A Is Mediated by Extracellular Matrix. Biochemistry. 34(28). 9249–9256. 35 indexed citations
17.
Banda, Michael J., Audie Rice, Gail L. Griffin, & Robert M. Senior. (1988). The inhibitory complex of human alpha 1-proteinase inhibitor and human leukocyte elastase is a neutrophil chemoattractant.. The Journal of Experimental Medicine. 167(5). 1608–1615. 116 indexed citations
18.
Banda, Michael J., Audie Rice, Gail L. Griffin, & Robert M. Senior. (1988). Alpha 1-proteinase inhibitor is a neutrophil chemoattractant after proteolytic inactivation by macrophage elastase.. Journal of Biological Chemistry. 263(9). 4481–4484. 134 indexed citations
19.
Wang, Ching C., et al.. (1984). Differential effects of inhibitors of purine metabolism on two trichomonad species. Biochemical Pharmacology. 33(8). 1323–1329. 25 indexed citations
20.
Wang, Ching C., Alice L. Wang, & Audie Rice. (1984). Tritrichomonas foetus: Partly defined cultivation medium for study of the purine and pyrimidine metabolism. Experimental Parasitology. 57(1). 68–75. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masaki Ri Breakdown of academic impact, for papers by Jiro Kikuchi Breakdown of academic impact, for papers by J I Johnson Breakdown of academic impact, for papers by Lisa Roberts Breakdown of academic impact, for papers by Francisco Adrián Breakdown of academic impact, for papers by Joanna Opalinska Breakdown of academic impact, for papers by Maeva Dufies Breakdown of academic impact, for papers by G Schwab Breakdown of academic impact, for papers by Amanda L. Christie Breakdown of academic impact, for papers by Gerrard Teoh
Rankless by CCL
2026